State Street’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
1,241,658
+65,110
| +6% | +$574K | ﹤0.01% | 2544 |
|
|
2025
Q1 | $8.81M | Buy |
1,176,548
+3,992
| +0.3% | +$29.9K | ﹤0.01% | 2610 |
|
|
2024
Q4 | $9.78M | Buy |
1,172,556
+399,731
| +52% | +$3.33M | ﹤0.01% | 2641 |
|
|
2024
Q3 | $5.36M | Buy |
772,825
+52,966
| +7% | +$368K | ﹤0.01% | 2936 |
|
|
2024
Q2 | $3.53M | Buy |
719,859
+36,687
| +5% | +$180K | ﹤0.01% | 3079 |
|
|
2024
Q1 | $3.96M | Buy |
683,172
+47,112
| +7% | +$273K | ﹤0.01% | 3017 |
|
|
2023
Q4 | $4.17M | Buy |
636,060
+7,833
| +1% | +$51.3K | ﹤0.01% | 3035 |
|
|
2023
Q3 | $3.03M | Buy |
628,227
+33,814
| +6% | +$163K | ﹤0.01% | 3152 |
|
|
2023
Q2 | $3.03M | Buy |
594,413
+484,373
| +440% | +$2.47M | ﹤0.01% | 3224 |
|
|
2023
Q1 | $605K | Buy |
110,040
+7,400
| +7% | +$40.7K | ﹤0.01% | 3675 |
|
|
2022
Q4 | $471K | Hold |
102,640
| – | – | ﹤0.01% | 3788 |
|
|
2022
Q3 | $640K | Hold |
102,640
| – | – | ﹤0.01% | 3690 |
|
|
2022
Q2 | $458K | Sell |
102,640
-448,975
| -81% | -$2M | ﹤0.01% | 3860 |
|
|
2022
Q1 | $2.78M | Buy |
551,615
+12,798
| +2% | +$64.4K | ﹤0.01% | 3444 |
|
|
2021
Q4 | $4.69M | Sell |
538,817
-7,732
| -1% | -$67.3K | ﹤0.01% | 3272 |
|
|
2021
Q3 | $5.1M | Buy |
546,549
+52,741
| +11% | +$492K | ﹤0.01% | 3230 |
|
|
2021
Q2 | $6.33M | Buy |
+493,808
| New | +$6.33M | ﹤0.01% | 3131 |
|